Evidence map›Paper›PMID 38800585›Full record

ArticleInfection and drug resistance2024

Combination Therapy for OXA-48 Carbapenemase-Producing

Yiyu Chen, Chuxuan Fang, Jun Luo, Xueling Pan, Zongyan Gao, Shuangyi Tang, Meng Li

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neonates: Clinical Characteristics and Antimicrobial Therapy.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yiyu ChenDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.ORCID 0000-0002-9351-4830
Chuxuan FangDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Jun LuoDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Xueling PanNewborn ICU, Guigang Maternal and Child Health Care Hospital, Guigang City, Guangxi, People's Republic of China.
Zongyan GaoNewborn ICU, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Shuangyi TangDepartment of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Meng LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.ORCID 0000-0001-5848-3832

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of carbapenem-resistant

Indexed as

aztreonamceftazidime–avibactamKlebsiella pneumoniaeOXA-48premature infant

Identifiers

PMID38800585
PMCPMC11122319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.